About this episode
Scott Wapner and the Investment Committee debate the post-election surge and how long it might last. Plus, Jim Lebenthal buying more of one pharma stock getting slammed today, he reveals why. And later, the desk gives you the setup on earnings this week.
Investment Committee Disclosures
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
Get every episode summarized
Each time Halftime Report publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from Halftime Report
Trading Ahead of the Apple iPhone Event & the CPI Report 9/8/26
Halftime Report
The Return of the "Magnificent Seven:" The Investment Committee's Strategy 9/4/2...
Halftime Report
Snowflake Surges on Q2 Earnings: The Investment Committee's Software Strategy 9/...
Halftime Report
Time to Be Cautious on Stocks? 9/2/26
Halftime Report